Symbols / CODX Stock $4.50 -10.89% Co-Diagnostics, Inc.

Healthcare • Medical Devices • United States • NCM
CODX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Dwight H. Egan
Exch · Country NCM · United States
Market Cap 16.58M
Enterprise Value 10.01M
Income -48.50M
Sales 718.17K
FCF (ttm) —
Book/sh 4.45
Cash/sh 2.29
Employees 115
Insider 10d —
IPO Jul 12, 2017
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.37
PEG —
P/S 23.09
P/B 1.01
P/C —
EV/EBITDA -0.33
EV/Sales 13.94
Quick Ratio 1.94
Current Ratio 2.28
Debt/Eq 12.66
LT Debt/Eq —
EPS (ttm) -32.26
EPS next Y -12.00
EPS Growth —
Revenue Growth 190.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-14
Earnings (prior) 2026-05-14
ROA -52.09%
ROE -151.66%
ROIC —
Gross Margin 45.06%
Oper. Margin -63.09%
Profit Margin 0.00%
Shs Outstand 3.69M
Shs Float 3.50M
Insider Own 3.60%
Instit Own 9.53%
Short Float 9.80%
Short Ratio 0.02
Short Interest 349.39K
52W High 46.50
vs 52W High -90.32%
52W Low 1.26
vs 52W Low 257.14%
Beta —
Impl. Vol. —
Rel Volume 0.05
Avg Volume 6.71M
Volume 321.82K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom Hold
Prev Close $5.05
Price $4.50
Change -10.89%
About

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$4.50
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$4.50
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-26 init Maxim Group — → Buy $2
2025-11-24 reit HC Wainwright & Co. Neutral → Neutral —
2025-10-28 main D. Boral Capital Buy → Buy $3
2025-10-16 main D. Boral Capital Buy → Buy $3
2025-09-19 main D. Boral Capital Buy → Buy $3
2025-09-17 main D. Boral Capital Buy → Buy $10
2025-08-15 main D. Boral Capital Buy → Buy $10
2025-04-28 init D. Boral Capital — → Buy $10
2025-03-28 main HC Wainwright & Co. Neutral → Neutral $1
2024-11-11 reit HC Wainwright & Co. Neutral → Neutral $2
2024-08-12 main HC Wainwright & Co. Neutral → Neutral $2
2024-06-17 reit HC Wainwright & Co. Neutral → Neutral $2
2024-05-13 main HC Wainwright & Co. Neutral → Neutral $2
2024-03-15 main HC Wainwright & Co. Neutral → Neutral $3
2023-12-29 reit HC Wainwright & Co. Neutral → Neutral $3
2023-11-13 main HC Wainwright & Co. Neutral → Neutral $3
2023-08-14 main HC Wainwright & Co. Neutral → Neutral $2
2023-05-15 reit HC Wainwright & Co. Neutral → Neutral $3
2023-03-20 down HC Wainwright & Co. Buy → Neutral $3
2023-02-23 reit HC Wainwright & Co. — → Buy $6
News
RSS: Latest CODX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-22 SERBIN RICHARD S Director — 5,695 $5.07 $28,874
2026-05-22 EGAN DWIGHT H. Chief Executive Officer — 13,750 $5.07 $69,712
2026-05-22 NELSON JAMES B Director — 5,695 $5.07 $28,874
2026-05-22 MURPHY EDWARD L. Director — 5,695 $5.07 $28,874
2026-05-22 DURENARD EUGENE A Director — 5,695 $5.07 $28,874
2026-05-22 BROWN BRIAN LEE Chief Financial Officer — 11,250 $5.07 $57,038
2026-05-22 ABBOTT RICHARD DAVID President — 9,793 $5.07 $49,651
2026-05-22 SERBIN RICHARD S Director — 1,695 $0.00 $0
2026-05-22 EGAN DWIGHT H. Chief Executive Officer — 4,584 $0.00 $0
2026-05-22 NELSON JAMES B Director — 1,695 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.62
-84.10%
3.92
-42.53%
6.81
-80.09%
34.22
Operating Revenue
0.62
-84.10%
3.92
-42.53%
6.81
-80.09%
34.22
Cost Of Revenue
0.22
-77.74%
1.00
-76.13%
4.18
-23.65%
5.48
Reconciled Cost Of Revenue
0.22
-77.74%
1.00
-76.13%
4.18
-23.65%
5.48
Gross Profit
0.40
-86.28%
2.92
+11.00%
2.63
-90.86%
28.74
Operating Expense
31.68
-26.31%
43.00
-5.15%
45.33
+12.41%
40.33
Research And Development
19.14
-8.78%
20.98
-8.64%
22.96
+31.68%
17.44
Selling General And Administration
11.44
-44.58%
20.64
-2.36%
21.14
-2.16%
21.61
Selling And Marketing Expense
2.38
-46.89%
4.48
-34.65%
6.86
-6.59%
7.34
General And Administrative Expense
9.06
-43.94%
16.16
+13.15%
14.28
+0.12%
14.26
Other Gand A
9.06
-43.94%
16.16
+13.15%
14.28
+0.12%
14.26
Total Expenses
31.91
-27.48%
44.00
-11.15%
49.52
+8.10%
45.81
Operating Income
-31.28
+21.95%
-40.08
+6.15%
-42.71
-268.43%
-11.59
Total Operating Income As Reported
-50.17
-25.16%
-40.08
+6.15%
-42.71
-58.29%
-26.98
EBITDA
-30.18
+22.03%
-38.70
+6.68%
-41.48
-302.34%
-10.31
Normalized EBITDA
-12.70
+68.48%
-40.30
+10.07%
-44.81
-1571.00%
-2.68
Reconciled Depreciation
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
EBIT
-31.28
+21.95%
-40.08
+6.15%
-42.71
-268.43%
-11.59
Total Unusual Items
-17.48
-1196.37%
1.59
-52.18%
3.33
+143.70%
-7.63
Total Unusual Items Excluding Goodwill
-17.48
-1196.37%
1.59
-52.18%
3.33
+143.70%
-7.63
Special Income Charges
-18.16
-2610.98%
0.72
-33.65%
1.09
+114.29%
-7.63
Impairment Of Capital Assets
18.88
0.00
0.00
-100.00%
15.39
Restructuring And Mergern Acquisition
-0.81
-12.73%
-0.71
+34.57%
-1.09
+86.17%
-7.90
Net Income
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Pretax Income
-48.51
-29.08%
-37.58
+1.39%
-38.11
-102.21%
-18.85
Net Non Operating Interest Income Expense
0.29
-73.17%
1.09
-6.03%
1.16
+65.03%
0.70
Net Interest Income
0.29
-73.17%
1.09
-6.03%
1.16
+65.03%
0.70
Interest Income Non Operating
0.29
-73.17%
1.09
-6.03%
1.16
+65.03%
0.70
Interest Income
0.29
-73.17%
1.09
-6.03%
1.16
+65.03%
0.70
Other Income Expense
-17.52
-1344.56%
1.41
-59.00%
3.43
+143.14%
-7.96
Gain On Sale Of Security
0.68
-21.52%
0.87
-61.18%
2.24
—
Tax Provision
-1.62
-2916.86%
0.06
+102.07%
-2.78
+39.73%
-4.61
Tax Rate For Calcs
0.00
-84.29%
0.00
+187.67%
0.00
-70.20%
0.00
Tax Effect Of Unusual Items
-0.58
-272.29%
0.33
+37.57%
0.24
+113.02%
-1.87
Net Income Including Noncontrolling Interests
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Net Income From Continuing Operation Net Minority Interest
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Net Income From Continuing And Discontinued Operation
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Net Income Continuous Operations
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Normalized Income
-30.00
+22.88%
-38.90
-1.24%
-38.42
-353.10%
-8.48
Net Income Common Stockholders
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Diluted EPS
-35.25
+5.29%
-37.22
-3.39%
-36.00
-166.67%
-13.50
Basic EPS
-35.25
+5.29%
-37.22
-3.39%
-36.00
-166.67%
-13.50
Basic Average Shares
1.33
+31.55%
1.01
+3.37%
0.98
-6.77%
1.05
Diluted Average Shares
1.33
+31.55%
1.01
+3.37%
0.98
-6.77%
1.05
Diluted NI Availto Com Stockholders
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Depreciation Amortization Depletion Income Statement
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
Depreciation And Amortization In Income Statement
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
Earnings From Equity Interest
-0.05
+75.12%
-0.19
-284.77%
0.10
+130.24%
-0.33
Gain On Sale Of PPE
-0.08
-1094.10%
0.01
+421.61%
-0.00
+98.13%
-0.14
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
24.74
-61.07%
63.56
-33.32%
95.32
-22.56%
123.09
Current Assets
13.69
-57.59%
32.29
-48.03%
62.14
-32.99%
92.73
Cash Cash Equivalents And Short Term Investments
11.88
-60.05%
29.75
-49.19%
58.55
-27.95%
81.26
Cash And Cash Equivalents
11.88
+304.71%
2.94
-80.31%
14.92
-35.07%
22.97
Cash Equivalents
—
0.00
-100.00%
10.60
+4.54%
10.14
Cash Financial
11.88
+304.71%
2.94
-31.98%
4.32
-66.36%
12.83
Other Short Term Investments
0.00
-100.00%
26.81
-38.55%
43.63
-25.15%
58.29
Receivables
0.23
+77.22%
0.13
-59.93%
0.33
-93.87%
5.40
Accounts Receivable
0.19
+43.60%
0.13
-56.38%
0.30
-91.20%
3.45
Gross Accounts Receivable
0.23
-4.89%
0.24
-51.89%
0.50
-92.30%
6.55
Allowance For Doubtful Accounts Receivable
-0.04
+63.31%
-0.11
+45.07%
-0.20
+93.53%
-3.10
Taxes Receivable
0.04
0.00
-100.00%
0.03
-98.56%
1.87
Inventory
0.99
-7.49%
1.07
-35.56%
1.66
-68.65%
5.31
Raw Materials
0.48
-4.99%
0.51
-47.58%
0.96
-75.79%
3.98
Finished Goods
0.51
-9.71%
0.57
-19.01%
0.70
-47.22%
1.33
Prepaid Assets
—
—
—
—
Other Current Assets
0.58
-56.56%
1.34
-16.18%
1.60
+109.82%
0.76
Total Non Current Assets
11.05
-64.67%
31.27
-5.75%
33.18
+9.31%
30.35
Net PPE
3.48
-28.64%
4.88
-18.76%
6.00
+106.16%
2.91
Gross PPE
7.39
-9.42%
8.16
-0.95%
8.23
+92.23%
4.28
Accumulated Depreciation
-3.91
-19.16%
-3.28
-46.96%
-2.23
-62.69%
-1.37
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.17
+0.00%
0.17
+0.00%
0.17
+55.00%
0.11
Other Properties
6.25
-11.22%
7.04
-6.35%
7.51
+90.35%
3.95
Leases
0.97
+2.21%
0.95
+72.73%
0.55
+143.89%
0.22
Goodwill And Other Intangible Assets
7.22
-72.34%
26.10
-1.15%
26.40
-1.36%
26.77
Goodwill
—
—
—
0.00
Other Intangible Assets
7.22
-72.34%
26.10
-1.15%
26.40
-1.36%
26.77
Investments And Advances
0.35
+19.12%
0.29
-61.95%
0.77
+14.97%
0.67
Long Term Equity Investment
0.35
+19.12%
0.29
-61.95%
0.77
+14.97%
0.67
Non Current Deferred Assets
—
—
—
—
Non Current Deferred Taxes Assets
—
—
—
—
Total Liabilities Net Minority Interest
4.11
-57.54%
9.69
+4.09%
9.31
+8.65%
8.57
Current Liabilities
3.54
-51.62%
7.32
+27.28%
5.75
+48.38%
3.87
Payables And Accrued Expenses
2.74
-53.15%
5.86
+60.23%
3.66
+93.72%
1.89
Payables
1.88
-42.98%
3.29
+122.27%
1.48
+55.64%
0.95
Accounts Payable
1.88
-42.98%
3.29
+122.27%
1.48
+55.64%
0.95
Current Accrued Expenses
0.87
-66.23%
2.56
+17.91%
2.17
+132.54%
0.93
Total Tax Payable
—
—
—
0.00
Income Tax Payable
—
—
—
0.00
Current Debt And Capital Lease Obligation
0.66
-27.67%
0.92
+9.21%
0.84
+182.09%
0.30
Current Capital Lease Obligation
0.66
-27.67%
0.92
+9.21%
0.84
+182.09%
0.30
Current Deferred Liabilities
0.01
-63.78%
0.04
-88.73%
0.36
0.00
Current Deferred Revenue
0.01
-63.78%
0.04
-88.73%
0.36
0.00
Other Current Liabilities
0.12
-76.33%
0.50
-43.61%
0.89
-47.22%
1.69
Total Non Current Liabilities Net Minority Interest
0.57
-75.79%
2.37
-33.35%
3.56
-24.15%
4.69
Long Term Debt And Capital Lease Obligation
0.57
-53.56%
1.24
-42.54%
2.15
+4144.26%
0.05
Long Term Capital Lease Obligation
0.57
-53.56%
1.24
-42.54%
2.15
+4144.26%
0.05
Tradeand Other Payables Non Current
0.00
-100.00%
0.71
+8.26%
0.66
-44.20%
1.18
Non Current Deferred Liabilities
—
—
0.00
-100.00%
2.42
Non Current Deferred Taxes Liabilities
—
—
0.00
-100.00%
2.42
Other Non Current Liabilities
—
0.42
-43.58%
0.75
-28.27%
1.04
Stockholders Equity
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Common Stock Equity
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Capital Stock
0.07
+78.62%
0.04
+4.97%
0.04
+3.90%
0.03
Common Stock
0.07
+78.62%
0.04
+4.97%
0.04
+3.90%
0.03
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
2.26
+78.62%
1.26
+4.97%
1.20
+3.90%
1.16
Ordinary Shares Number
2.10
+90.15%
1.10
+5.74%
1.04
+1.25%
1.03
Treasury Shares Number
0.16
+0.00%
0.16
+0.00%
0.16
+24.91%
0.13
Additional Paid In Capital
116.51
+13.70%
102.47
+5.85%
96.81
+9.42%
88.47
Retained Earnings
-80.37
-140.08%
-33.48
-828.06%
4.60
-88.48%
39.93
Gains Losses Not Affecting Retained Earnings
0.00
-100.00%
0.42
+185.24%
0.15
-49.96%
0.29
Treasury Stock
15.58
+0.00%
15.58
+0.00%
15.58
+9.60%
14.21
Other Equity Adjustments
—
0.42
+185.24%
0.15
-49.96%
0.29
Total Equity Gross Minority Interest
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Total Capitalization
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Working Capital
10.15
-59.35%
24.98
-55.71%
56.39
-36.54%
88.86
Invested Capital
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Total Debt
1.24
-42.54%
2.15
-28.03%
2.99
+759.56%
0.35
Capital Lease Obligations
1.24
-42.54%
2.15
-28.03%
2.99
+759.56%
0.35
Net Tangible Assets
13.41
-51.72%
27.77
-53.41%
59.61
-32.07%
87.75
Tangible Book Value
13.41
-51.72%
27.77
-53.41%
59.61
-32.07%
87.75
Investmentsin Joint Venturesat Cost
0.35
+19.12%
0.29
-61.95%
0.77
+14.97%
0.67
Non Current Accrued Expenses
—
—
—
—
Non Current Note Receivables
—
—
—
0.00
Notes Receivable
—
—
0.00
-100.00%
0.07
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-29.14
+0.06%
-29.16
-32.03%
-22.08
-436.17%
6.57
Cash Flow From Continuing Operating Activities
-29.14
+0.06%
-29.16
-32.03%
-22.08
-436.17%
6.57
Net Income From Continuing Operations
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Depreciation Amortization Depletion
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
Depreciation And Amortization
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
Other Non Cash Items
-0.68
+3.18%
-0.70
+79.74%
-3.46
+72.69%
-12.68
Stock Based Compensation
2.25
-58.64%
5.43
-34.81%
8.34
+10.52%
7.54
Provisionand Write Offof Assets
-0.03
-72.97%
-0.02
-102.45%
0.61
-75.10%
2.46
Asset Impairment Charge
18.83
+5667.34%
0.33
-89.90%
3.23
-79.19%
15.54
Deferred Tax
—
0.00
+100.00%
-2.42
+49.73%
-4.81
Deferred Income Tax
—
0.00
+100.00%
-2.42
+49.73%
-4.81
Operating Gains Losses
-0.55
+19.96%
-0.69
+70.40%
-2.34
-596.98%
0.47
Gain Loss On Investment Securities
-0.68
+21.52%
-0.87
+61.18%
-2.24
—
Change In Working Capital
-3.17
-214.98%
2.75
-51.17%
5.64
-8.89%
6.19
Change In Receivables
-0.03
-117.06%
0.19
-92.65%
2.54
-83.00%
14.92
Changes In Account Receivables
-0.03
-117.06%
0.19
-92.65%
2.54
-83.00%
14.92
Change In Inventory
0.13
-50.56%
0.27
-35.74%
0.41
+111.25%
-3.67
Change In Prepaid Assets
0.59
+42.20%
0.41
-61.94%
1.08
+583.07%
-0.22
Change In Payables And Accrued Expense
-3.83
-272.97%
2.21
+77.52%
1.25
+126.60%
-4.69
Change In Payable
-3.83
-272.97%
2.21
+77.52%
1.25
+126.60%
-4.69
Change In Account Payable
-3.11
-244.26%
2.16
+22.03%
1.77
+171.19%
-2.48
Change In Other Working Capital
-0.03
+91.90%
-0.32
-188.73%
0.36
+341.63%
-0.15
Investing Cash Flow
26.27
+53.91%
17.07
+10.93%
15.39
+126.46%
-58.17
Cash Flow From Continuing Investing Activities
26.27
+53.91%
17.07
+10.93%
15.39
+126.46%
-58.17
Net PPE Purchase And Sale
-0.70
+6.45%
-0.75
+45.19%
-1.37
+4.36%
-1.43
Purchase Of PPE
-0.70
+6.45%
-0.75
+45.19%
-1.37
+4.36%
-1.43
Capital Expenditure
-0.70
+6.45%
-0.75
+45.19%
-1.37
+4.36%
-1.43
Net Investment Purchase And Sale
27.08
+50.73%
17.96
+7.21%
16.75
+129.53%
-56.74
Purchase Of Investment
-6.59
+83.85%
-40.80
+63.07%
-110.50
-62.51%
-68.00
Sale Of Investment
33.67
-42.71%
58.77
-53.82%
127.25
+1030.60%
11.26
Net Business Purchase And Sale
-0.10
+28.65%
-0.14
0.00
0.00
Purchase Of Business
-0.10
+28.65%
-0.14
0.00
—
Financing Cash Flow
11.81
+11266.69%
0.10
+107.62%
-1.36
+90.28%
-14.03
Cash Flow From Continuing Financing Activities
11.81
+11266.69%
0.10
+107.62%
-1.36
+90.28%
-14.03
Net Common Stock Issuance
11.80
+11254.66%
0.10
+107.62%
-1.36
+90.40%
-14.21
Common Stock Payments
—
0.00
+100.00%
-1.36
+90.40%
-14.21
Repurchase Of Capital Stock
—
0.00
+100.00%
-1.36
+90.40%
-14.21
Proceeds From Stock Option Exercised
0.01
0.00
0.00
-100.00%
0.18
Changes In Cash
8.95
+174.69%
-11.98
-48.70%
-8.06
+87.72%
-65.63
Beginning Cash Position
2.94
-80.31%
14.92
-35.07%
22.97
-74.07%
88.61
End Cash Position
11.88
+304.71%
2.94
-80.31%
14.92
-35.07%
22.97
Free Cash Flow
-29.84
+0.22%
-29.90
-27.54%
-23.45
-556.06%
5.14
Interest Paid Supplemental Data
—
—
0.00
0.00
Income Tax Paid Supplemental Data
0.86
0.00
-100.00%
0.06
-98.76%
4.50
Change In Income Tax Payable
-0.71
-1410.47%
0.05
+110.43%
-0.52
+76.28%
-2.20
Change In Tax Payable
-0.71
-1410.47%
0.05
+110.43%
-0.52
+76.28%
-2.20
Common Stock Issuance
11.80
+11254.66%
0.10
0.00
—
Earnings Losses From Equity Investments
0.05
-75.12%
0.19
+284.77%
-0.10
-130.24%
0.33
Issuance Of Capital Stock
11.80
+11254.66%
0.10
0.00
—
Sale Of Business
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category